FAQ

A meeting should be arranged with the Director, Dr. Jerome Ritz, to discuss the planned clinical protocol and begin the process for clinical trial development.  You may set up the meeting with the Director by emailing Gerry Miceli at gerry_miceli@dfci.harvard.edu.

Charges are developed and are based on per patient or per procedure costs.  Invoices are issued monthly for the procedure performed.

Ongoing dialogue between the investigators and the facility director will occur during the course of the trial.

• 
• 
  • Biostatistics
  • Cancer Pharmacology
  • Cancer Proteomics
  • Cell Manipulation
    • Services and Policies
    • Pricing
    • References
    • Feedback
    • Contact
    • FAQ
  • Community Practice
  • Cytogenetics (Pathology)
  • DNA Resource
  • Health Communication
  • High-Throughput Polymorphism Detection
  • Monoclonal Antibody
  • Pathology Specimen Locator (Pathology)
  • Research Pharmacy
  • RNAi
  • Rodent Histopathology (Pathology)
  • Specialized Histopathology Services (Pathology)
  • Tissue Microarray and Imaging (Pathology)
  • Tumor Imaging Metrics
  • Vector
• 
• 
• 
• 
•